ALK-001

· Alkeus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ALK-001, covering 2025-04-27 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of ALK-001 on the Progression of Stargardt Disease [Phase 3]